In a study published in the Journal of Infectious Diseases, lead author Dr. Richard Whitley of the University of Alabama at Birmingham pointed out that, at the time of the study, immunization of older children had not yet become a priority of the U.S. Public Health Service. The researchers said, “As a consequence, the importance of antiviral agents, particularly neuraminidase (NA) inhibitors, cannot be overemphasized."